MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)
Quantifies end-stage liver disease for transplant planning.
We’ve updated and combined our MELD scores into one page. Clinicians can choose the formula that best fits their needs: the original MELD score; the current MELD-Na used by UNOS/OPTN, and the 2022 MELD 3.0 score. Click here to view.
Note: This is the pre-2016 MELD which does not include serum sodium level, as non-US transplant societies are still using the original MELD formula. The newer MELD Score is listed as “MELD Score”.
Result:
Patrick S. Kamath, MD, is a professor of gastroenterology and hepatology at the Mayo Clinic in Rochester, Minnesota. His research interests include acute-on-chronic liver failure, nonalcoholic fatty liver disease, polycystic liver disease, Budd-Chiari syndrome and hereditary hemorrhagic telangiectasia. Dr. Kamath is internationally renowned as a leading researcher in hepatology and has also won numerous awards as an educator.